Periodic Reporting for period 1 - RNAmpMax (Maximization of amplification of next-generation RNA replicon vaccines through synergistic molecular and formulation design)

Ribonucleic acid (RNA) is a cutting-edge vaccine platform, and the speed and scalability of this strategy has been highlighted during the COVID-19 pandemic. It is possible to make a vaccine against any pathogen with a known protein target, and the currently approved RNA...